IM Cannabis PE Ratio 2021-2025 | IMCC
Current and historical p/e ratio for IM Cannabis (IMCC) from 2021 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. IM Cannabis PE ratio as of June 04, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
IM Cannabis PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2025-06-04 | 2.75 | 0.00 | |
2025-03-31 | 1.51 | $-0.64 | 0.00 |
2024-12-31 | 2.33 | $-2.56 | 0.00 |
2024-09-30 | 2.38 | $-3.41 | 0.00 |
2024-06-30 | 2.76 | $-3.83 | 0.00 |
2024-03-31 | 3.18 | $-4.80 | 0.00 |
2023-12-31 | 2.14 | $-2.82 | 0.00 |
2023-09-30 | 4.31 | $-1.74 | 0.00 |
2023-06-30 | 5.51 | $-84.40 | 0.00 |
2023-03-31 | 4.30 | $-97.66 | 0.00 |
2022-12-31 | 5.85 | $-105.58 | 0.00 |
2022-09-30 | 24.56 | $-114.58 | 0.00 |
2022-06-30 | 38.30 | $-39.59 | 0.00 |
2022-03-31 | 128.40 | $-36.59 | 0.00 |
2021-12-31 | 200.40 | $-31.79 | 0.00 |
2021-09-30 | 211.80 | $-45.59 | 0.00 |
2021-06-30 | 318.60 | $-37.19 | 0.00 |
2021-03-31 | 427.50 | $-28.19 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $0.006B | $0.039B |
IM Cannabis Corp. is an MCO in the medical and adult-use recreational cannabis sector. It operates principally in Israel, Germany and Canada. IM Cannabis Corp. is headquartered in Israel. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $232.634B | 27.97 |
Boston Scientific (BSX) | United States | $152.531B | 38.19 |
Stryker (SYK) | United States | $145.427B | 30.41 |
EssilorLuxottica (ESLOY) | France | $127.535B | 0.00 |
Medtronic (MDT) | Ireland | $109.709B | 15.55 |
Haleon (HLN) | United Kingdom | $49.754B | 28.33 |
Lonza Group Ag (LZAGY) | Switzerland | $49.468B | 0.00 |
ResMed (RMD) | United States | $36.224B | 27.21 |
GE HealthCare Technologies (GEHC) | United States | $32.583B | 15.47 |
Agilent Technologies (A) | United States | $32.148B | 20.88 |
Terumo (TRUMY) | Japan | $26.857B | 34.88 |
Insulet (PODD) | United States | $22.748B | 89.29 |
Koninklijke Philips (PHG) | Netherlands | $21.431B | 15.40 |
Zimmer Biomet Holdings (ZBH) | United States | $18.172B | 11.67 |
Baxter (BAX) | United States | $15.441B | 11.53 |
Smith & Nephew SNATS (SNN) | United Kingdom | $12.754B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
Demant (WILYY) | Denmark | $8.637B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $6.002B | 20.89 |
Lantheus Holdings (LNTH) | United States | $5.375B | 13.56 |
Prestige Consumer Healthcare (PBH) | United States | $4.194B | 18.74 |
Perrigo (PRGO) | Ireland | $3.646B | 9.24 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
Haemonetics (HAE) | United States | $3.346B | 15.24 |
ICU Medical (ICUI) | United States | $3.213B | 23.69 |
Envista Holdings (NVST) | United States | $3.174B | 26.38 |
GN Store Nord (GNNDY) | Denmark | $2.155B | 17.85 |
QuidelOrtho (QDEL) | United States | $2.048B | 14.09 |
LeMaitre Vascular (LMAT) | United States | $1.872B | 41.85 |
AtriCure (ATRC) | United States | $1.719B | 0.00 |
Neogen (NEOG) | United States | $1.302B | 16.67 |
Acuren (TIC) | United States | $1.300B | 0.00 |
AdaptHealth (AHCO) | United States | $1.196B | 12.14 |
Green Thumb Industries (GTBIF) | United States | $1.110B | 24.97 |
BioLife Solutions (BLFS) | United States | $1.016B | 0.00 |
Kestra Medical Technologies (KMTS) | United States | $1.008B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.986B | 12.60 |
InMode (INMD) | Israel | $0.930B | 9.37 |
Evolus (EOLS) | United States | $0.642B | 0.00 |
CeriBell (CBLL) | United States | $0.612B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.565B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.544B | 0.00 |
Valneva SE (VALN) | France | $0.519B | 0.00 |
Owens & Minor (OMI) | United States | $0.517B | 4.29 |
Capricor Therapeutics (CAPR) | United States | $0.509B | 0.00 |
Surmodics (SRDX) | United States | $0.422B | 0.00 |
Tilray Brands (TLRY) | Canada | $0.403B | 0.00 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
SNDL (SNDL) | Canada | $0.336B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.326B | 11.98 |
Aurora Cannabis (ACB) | Canada | $0.302B | 53.70 |
Cresco Labs (CRLBF) | United States | $0.277B | 0.00 |
Cerus (CERS) | United States | $0.275B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.268B | 22.63 |
Sanara MedTech (SMTI) | United States | $0.259B | 0.00 |
ZimVie (ZIMV) | United States | $0.258B | 11.75 |
Sanuwave Health (SNWV) | United States | $0.242B | 0.00 |
Canopy Growth (CGC) | Canada | $0.222B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.221B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.216B | 0.00 |
Quanterix (QTRX) | United States | $0.211B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.196B | 0.00 |
Biote (BTMD) | United States | $0.194B | 5.46 |
Brainsway (BWAY) | Israel | $0.192B | 50.95 |
High Tide (HITI) | Canada | $0.185B | 0.00 |
Omeros (OMER) | United States | $0.184B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.182B | 14.81 |
Organigram Global (OGI) | Canada | $0.178B | 0.00 |
Exagen (XGN) | United States | $0.157B | 0.00 |
Vireo Growth (VREOF) | United States | $0.139B | 0.00 |
FitLife Brands (FTLF) | United States | $0.135B | 16.58 |
Jin Medical (ZJYL) | China | $0.122B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.098B | 0.00 |
MacroGenics (MGNX) | United States | $0.095B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
Veru (VERU) | United States | $0.090B | 0.00 |
Fonar (FONR) | United States | $0.090B | 11.62 |
Agape ATP (ATPC) | $0.081B | 0.00 | |
Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
InterCure (INCR) | Israel | $0.070B | 0.00 |
Zynex (ZYXI) | United States | $0.065B | 0.00 |
Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
ImmuCell (ICCC) | United States | $0.062B | 0.00 |
Apyx Medical (APYX) | United States | $0.061B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
Modular Medical (MODD) | United States | $0.048B | 0.00 |
United-Guardian (UG) | United States | $0.037B | 12.94 |
Nephros (NEPH) | United States | $0.035B | 46.71 |
Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
Safety Shot (SHOT) | United States | $0.019B | 0.00 |
INLIF (INLF) | $0.017B | 0.00 | |
Flora Growth (FLGC) | United States | $0.015B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.011B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
Senestech (SNES) | United States | $0.005B | 0.00 |
GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
Akanda (AKAN) | Canada | $0.002B | 0.00 |
Sharps Technology (STSS) | United States | $0.000B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |